Skip to main content

CAC score may refine statin use in elderly


Noninvasive imaging identifies patients who can be spared statin therapy despite advanced age, shows an analysis of the BioImage cohort.


Focus on barriers improves glycaemic control in Type 2 diabetes

Blood glucose test 2

Customised approaches that specifically address barriers to care result in improved metabolic control in patients with Type 2 diabetes, shows the DROP A1C study.


Focused ultrasound thalamotomy expands treatment options in essential tremor


Focused ultrasound thalamotomy guided by magnetic resonance imaging reduces hand tremor in patients with essential tremor, research in The New England Journal of Medicine shows.


PROs best with bone marrow unrelated donor transplantation


For patients undergoing unrelated donor haematopoietic cell transplantation, bone marrow should be used as the graft source instead of peripheral blood, say researchers who found that bone marrow recipients fared better with respect to certain self-reported measures.

Headlines from across medwireNews

31-08-2016 | Cardiology | News | Article

Adanexanet substantially reduces anti-FXa in bleeding patients

Adanexanet rapidly reverses anti-factor Xa activity in patients with acute major bleeding associated with FXa inhibitors, preliminary results from the ANNEXA-4 study show.

31-08-2016 | Cardiology | News | Article

ICDs fail to reduce long-term mortality in non-ischaemic HF

Prophylactic implantable cardioverter–defibrillator use does not reduce long-term mortality in patients with symptomatic heart failure not caused by coronary artery disease, Danish research shows.

30-08-2016 | Cardiology | News | Article

CPAP does not prevent CV events in obstructive sleep apnoea patients

Treatment with continuous positive airway pressure improves quality of life but does not prevent cardiovascular events for patients with moderate-to-severe obstructive sleep apnoea and established CV disease, trial data show.

30-08-2016 | Cardiology | News | Article

Sacubitril–valsartan costs may be justified in NYHA class II-IV heart failure

Sacubitril–valsartan is cost-effective for the reduction of cardiovascular mortality and morbidity in patients with New York Heart Association class II to IV heart failure and reduced ejection fraction, US study findings indicate.

26-08-2016 | Arrhythmia | News | Article

Women at greater risk of post-ablation VT recurrence

Women are more likely than men to have recurrent ventricular tachycardia following ablation, despite having more favourable baseline characteristics, research shows.

25-08-2016 | Arrhythmia | News | Article

Sudden cardiac death prediction model developed for general population

Researchers have developed and validated a risk model for predicting sudden cardiac death in adults without a history of cardiovascular disease.

Beyond the news


medwireNews brings you coverage of the 2015 European Cancer Congress, held in Vienna, Austria.

Click through to read the full reports of the latest research.

Interested in paediatric endocrinology?

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.


Highlights from the 1st conference of the European Academy of Neurology in Berlin, Germany.

Click through to read research news from the conference.

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make your preferred medical news resource.

Meet the team

image credits